Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Long-term Depression01:05

Long-term Depression

33.3K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.3K
Long-term Depression01:03

Long-term Depression

3.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.4K
Tumor Progression02:07

Tumor Progression

7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
Secondary Motives: Power Motivation and Achievement Motivation01:27

Secondary Motives: Power Motivation and Achievement Motivation

582
Power motivation and achievement motivation are two essential social motives identified by psychologist David McClelland. These motives influence behavior in various personal and professional contexts, shaping how individuals interact with others and pursue their goals.
Power motivation is characterized by the desire to influence, control, or have an impact on others. It is shaped by an individual's experiences, social environment, and cultural context. People with high power motivation are...
582
Long-term Potentiation01:35

Long-term Potentiation

58.7K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
58.7K
Long-term Potentiation01:25

Long-term Potentiation

3.6K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shotgun metagenomic profiling of the gut microbiota in Parkinson's disease dementia and dementia with Lewy bodies.

Parkinsonism & related disorders·2026
Same author

HIV tri-specific killer engagers directly enhance NK cell function and safely expand NK cells in vivo.

Cell reports. Medicine·2026
Same author

In vivo reprogramming of cytotoxic effector CD8 T cells via fractalkine-conjugated mRNA-LNPs.

Science immunology·2026
Same author

Modulation of pulmonary IL-21 expression during latent TB and M. tuberculosis/SIV coinfection.

JCI insight·2026
Same author

TGF-β mediates epigenetic control of innate antiviral responses and SIV reservoir size.

Nature immunology·2026
Same author

Interleukin-6 restricts pre-thymic T cell lineage commitment of progenitors driving loss of SIV control.

bioRxiv : the preprint server for biology·2026
Same journal

Measuring neurocognitive impairment in virally suppressed HIV: HIV-associated neurocognitive disorders, HIV-associated brain injury problems and solutions.

Current opinion in HIV and AIDS·2026
Same journal

Learned young: HIV-1 germline-targeting vaccination in infants.

Current opinion in HIV and AIDS·2026
Same journal

Implications of HIV persistence and pathogenesis in microglia.

Current opinion in HIV and AIDS·2026
Same journal

Paediatric HIV cure section in Current Opinion in HIV and AIDS.

Current opinion in HIV and AIDS·2026
Same journal

Early intervention, lasting impact: benefits of early antiretroviral therapy and implications for posttreatment control.

Current opinion in HIV and AIDS·2026
Same journal

Natural killer cells in pediatric HIV cure strategies: from viral control to immunotherapeutics.

Current opinion in HIV and AIDS·2026
See all related articles

Related Experiment Video

Updated: Feb 9, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.4K

Progress in achieving long-term HIV remission.

Maria Pino1, Mirko Paiardini1,2, Vincent C Marconi1,2,3,4

  • 1Yerkes National Primate Research Center (YNPRC), Emory Vaccine Center (EVC), Emory University.

Current Opinion in HIV and AIDS
|June 12, 2018
PubMed
Summary
This summary is machine-generated.

Achieving HIV eradication faces major hurdles, including persistent infections and immune dysfunction. Promising strategies like ART optimization and gene editing aim for long-term HIV remission, not a complete cure.

More Related Videos

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3
11:10

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

Published on: December 27, 2010

12.8K
Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

9.2K

Related Experiment Videos

Last Updated: Feb 9, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.4K
Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3
11:10

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

Published on: December 27, 2010

12.8K
Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

9.2K

Area of Science:

  • Immunology
  • Virology
  • Infectious Diseases

Background:

  • Persistent latent HIV infection and chronic immune activation present significant barriers to eradicating the virus.
  • Previous attempts at HIV cure, inspired by the Berlin patient, have largely failed, shifting focus towards long-term remission.

Purpose of the Study:

  • To outline the primary obstacles hindering HIV eradication.
  • To evaluate the most promising therapeutic strategies currently under investigation for HIV cure.

Main Methods:

  • Review of current scientific literature on HIV persistence mechanisms.
  • Analysis of preclinical studies and clinical trials for novel HIV intervention strategies.
  • Discussion of clinical cases offering insights into potential HIV remission.

Main Results:

  • Key barriers include latent viral reservoirs and immune system dysregulation.
  • Long-term HIV remission is considered a more achievable goal than complete eradication.
  • Multiple strategies, including ART optimization, immunotherapy, therapeutic vaccines, and gene editing, are being explored.

Conclusions:

  • HIV eradication remains a significant challenge due to persistent viral reservoirs.
  • Focus is shifting towards achieving functional HIV cure through long-term remission.
  • Ongoing research into novel therapeutic strategies holds promise for controlling HIV without continuous antiretroviral therapy.